Patent Assignment
Reel/Frame 022153/0340
Corrective Assignment to Correct the One of the Inventors Was Omitted from the Assignment Previously Recorded on Reel 021974 Frame 0162. Assignor(S) Hereby Confirms the Inventors Wish to Assign U.S. Serial No. 12/296,739 to Abbott Gmbh Co. Kg.
Recorded: 2009-01-26
Pages: 15
Assignors
GRANDEL, ROLAND
Executed: 2008-11-18
BRAJE, WILFRIED MARTIN
Executed: 2008-12-03
HAUPT, ANDREAS
Executed: 2008-11-17
TURNER, SEAN COLM
Executed: 2008-12-10
LANGE, UDO
Executed: 2008-12-03
DRESCHER, KARLA
Executed: 2008-12-04
UNGER, LILIANE
Executed: 2008-12-03
PLATA, DAN
Executed: 2008-11-25
Assignee
ABBOTT GMBH CO. KG
MAX- PLANCK-RING 2, WIESBADEN, 65205, GERMANY
Covered Property
(1)
Aryloxyethylamine Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 12, 2008
From: GRANDEL, ROLAND; BRAJE, WILFRIED MARTIN; HAUPT, ANDREAS; TURNER, SEAN COLM
To: ABBOTT GMBH CO. KG
Reel/Frame 021974/0162 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030804/0836 →